LuxR, the Vibno fischeri luminescence gene (lux) activator, is the best-studied member ofa family of bacterial transcription factors required for cell density-dependent expression of specific genes involved in associations with eukaryotic hosts. Neither LuxR nor any other LuxR homolog has been shown to bind DNA directly. We have purified the LuxR C-terminal transcriptional activator domain from extracts of recombinant Escherichia coli in which this polypeptide was expressed. The purified polypeptide by itself binds to lux regulatory DNA upstream of the lux box, a 20-bp palindrome that is required for LuxR activity in vivo, but it does not bind to the lux box. However, the LuxR C-terminal domain together with RNA polymerase protects a region including the lux box and the lux operon promoter from DNase I cleavage. There is very little protection of the lux operon promoter region from DNase I digestion in the presence of RNA polymerase alone. Apparently, there is a synergistic binding of the LuxR C-terminal domain and RNA polymerase to the promoter region LuxR-facilitated autoinduction controls transcription of luminescence genes in Vibriofischeri. LuxR homologs occur in a number of different Gram-negative -bacteria, and these transcription factors are involved in a phenomenon termed quorum sensing and response (for recent reviews, see refs.
LuxR C-terminal domain and RNA polymerase to the lux box and luminescence gene promoter region. This description of DNA binding by the LuxR C-terminal domain should lead to an understanding ofthe molecular interactions ofthe LuxR family of transcriptional activators with regulatory DNA.
LuxR-facilitated autoinduction controls transcription of luminescence genes in Vibriofischeri. LuxR homologs occur in a number of different Gram-negative -bacteria, and these transcription factors are involved in a phenomenon termed quorum sensing and response (for recent reviews, see refs. 1-3). In quorum sensing, the cells produce an N-acylhomoserine lactone, the autoinducer. The V. fischeri autoinducer is N-(3-oxohexanoyl)homoserine lactone (4) . Cells of V. fischeri are freely permeable to the autoinducer, which therefore accumulates in the medium during growth (5) . When autoinducer reaches a sufficient concentration it binds to LuxR (6, 7) , which can then activate transcription of the luminescence (lux) genes. Thus autoinducer is a signal that allows communication between V. fischeri cells, enabling them to monitor their own population density. At low cell densities, the autoinducer will diffuse away from cells. At high cell densities, the autoinducer will reach a sufficient concentration, the cells will sense that a quorum has been attained, and transcription of the lux genes will be activated.
There are no reports ofin vitro activity for LuxR or any LuxR homolog. A general view of the mechanism of autoinduction in V.fischeri has been developed from molecular genetic analyses. These analyses were made possible by the cloning ofa fragment of V. fischeri DNA that encodes all of the functions necessary for autoinducible luminescence in Escherichia coli (8) . This V. flscheri DNA contains two divergent transcriptional units. One unit contains luxR, and the other unit, which is activated by the LuxR protein together with autoinducer, contains luxI, the gene required for autoinducer synthesis, and genes required for light emission (8) (9) (10) (Fig. 1) .
The lux box, a 20-bp inverted repeat centered at -40 bp from the start of luxI transcription ( Fig. 1) , is required for autoinduction of luminescence (11) and is thus a putative binding site for LuxR. The LuxR polypeptide contains 250 aa (10, 12) and consists oftwo domains (13, 14) . The C-terminal domain, which extends from around residue 160 to the C terminus, is thought to bind lux regulatory DNA and activate transcription of the luminescence genes (15) . The other domain, which binds autoinducer (7, (14) (15) (16) (17) , consists of the N-terminal 60-70%o of LuxR. In the absence of autoinducer the N-terminal domain inhibits transcriptional activation by the C-terminal domain. This inhibitory role is neutralized by autoinducer binding. In E. coli, truncated LuxR polypeptides consisting solely of the C-terminal domain can activate the lux genes in the absence of autoinducer (13) . LuxR is thought to function as an oligomer and residues in the region of 116-161 in the N-terminal domain appear to be critical for oligomerization (14) .
A barrier to developing an understanding of the mechanisms by which LuxR or LuxR homologs activate transcription has been an inability to demonstrate binding of any of these proteins to regulatory regions of target genes in vitro. Several obstacles have hindered development of an in vitro LuxR activity assay. When overexpressed in E. coli, LuxR forms insoluble inclusion bodies (18) . Furthermore, LuxR requires the assistance of Hsp60 to fold into an active form (19, 20) . Additionally, a number of other DNA-binding proteins, including CRP (21), LexA (21) , and Fnr (40) recognize sequences in the lux regulatory DNA. This has confounded attempts to use LuxR-containing cell extracts to study binding of LuxR to lux regulatory DNA. Finally, full-length LuxR is associated with the membrane fraction of crude V. fischeri cell extracts (22) . We have overcome these obstacles by purifying the C-terminal domain of LuxR and studying the DNA-binding activity of this polypeptide in vitro. We show that by itself this polypeptide binds lux regulatory DNA specifically but does not bind to the lux box. Together, the purified LuxR polypeptide and RNA polymerase (RNAP) bind synergistically to the lux box and the luxI promoter region.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture Conditions. We used E. coli XL1-Blue (23) containing pSC156 (13) to produce the 95-aa C-terminal fragment of LuxR, referred to as Abbreviations: CRP, cAMP receptor protein; RNAP, RNA polymerase.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. The following plasmids were used as templates for PCR synthesis of the target DNAs used in DNA mobility-shift experiments: pJE202, which contains the V. flscheri luxR, luxICDABEG gene cluster (8); pJHD506, which contains luxR, part of luxI, and the regulatory DNA between luxR and luxI except that there is a deletion of the central 12 bp of the 20-bp lux box (11); and pUC18 (25) .
Two plasmids were constructed for use as sources of DNA for DNase I protection experiments, pAMS103 and pAMS104. Both of these plasmids contained the lux regulatory DNA between luxR and luxI ( Fig. 1 ) cloned into the HincII site of pUC19 (25) . The lux regulatory DNA was prepared by PCR amplification from pJE202 for pAMS103, and pJHD506 for pAMS104. The primers for PCR amplification corresponded to nt 32-10 of the luxR open reading frame (luxRlA), and the luxI open reading frame (luxR2A) (Fig. 1 ). Standard procedures were used for PCR amplification and cloning (24) . To confirm that pAMS103 contained the intergenic lux regulatory DNA and that pAMS104 contained a similar lux fragment with a 12-bp deletion in the lux box, the nucleotide sequence of the V. fischeri DNA in these plasmids was determined by the dideoxy chain-termination method (26) using the pUC forward and reverse primers.
Purification of LuxRAN. 15 ,000 psi (1 psi = 6.89 kPa), the protease inhibitors phenylmethylsulfonyl fluoride (100 ug/ml), leupeptin (0.5 Ag/ml), and pepstatin A (0.7 ,g/ml) were added.
Remaining whole cells and cell debris were removed by centrifugation at 11,000 x g for 30 min at 4°C. The soluble cell extract was further clarified by ultracentrifugation at 100,000
x g for 1 hr. The clarified cell extract remaining in the supernatant fraction after ultracentrifugation was applied to an SP-Sepharose cation-exchange column (automated FPLC system; Pharmacia LKB). The column was equilibrated and washed with buffer A, and LuxRAN was then eluted at 600-750 mM NaCl in a linear gradient of0-1 M NaCl in buffer A. Column fractions were examined for LuxRAN by Western immunoblotting with LuxR antiserum (17) . The LuxRAN fractions were pooled, concentrated by ultrafiltration (Amicon), and applied to a Sephadex G-75 gel filtration column (2.6 cm x 65 cm, Pharmacia LKB). LuxRAN was eluted in buffer A plus 0.1 M NaCl. Fractions containing LuxRAN, identified by Western immunoblotting with anti-LuxR, were pooled and concentrated by ultrafitration. The gel filtration column was calibrated with protein standards (low molecular weight gel flltration calibration kit; Pharmacia LKB). Protein concentrations were estimated by the Bradford dye-binding procedure with reagents from BioRad. SDS/PAGE has been described (27, 28) .
DNA Mobility-Shift Assays. Gel shift assays were based on published procedures (29) . Reaction mixtures (60 ,ul) contained 3 nM radiolabeled DNA, 50 mM NaCl, 1 mM MgCl2, 0.002 p,g/,l. poly(dI-dC) (Boehringer Mannheim), acetylated bovine serum albumin (2 mg/ml), 1 mM dithiothreitol, 0.1 mM EDTA, and 10% glycerol in 40 mM Hepes (pH 7.4). Reactions were initiated by addition of LuxRAN, and proceeded at 30°C for 15 min. Reaction mixtures were separated by electrophoresis at 10 V/cm at 25°C in 4% polyacrylamide gels with recirculation of the buffer (20 mM Hepes/3 mM NaCl/l mM EDTA, pH 8.0). Radioactive bands were visualized by autoradiography as described (24) .
Radiolabeled DNAs for the mobility-shift experiments were generated by PCR. Fragments of lux regulatory DNA were generated from either pJE202 or pJHD506 using luxRlA and luxR2A (Fig. 1) as primers. With pJE202 as the template, a 282-bp DNA fragment containing the entire wild-type lux regulatory region was generated. A 270-bp fragment with a 12-bp deletion in the lux box was generated from pJHD506. A 157-bp DNA fragment extending from the crp box through the lux box and into the luxI open reading frame was generated from pJE202 with KD2 and luxR2A serving as primers (Fig. 1) . A 182-bp DNA fragment extending from the luxR open reading frame through the first 3 bp of the lux box was generated with pJE202 as a template and luxRlA and AMS2 as primers (Fig. 1) . The 104-bp pUC multiple cloning site was amplified from pUC18 by using the pUC forward and reverse primers (25) . The PCR products were radiolabeled by inclusion of [a-32P]dCTP in the PCR mixtures (24) .
DNase I Protection Experiments. DNase I protection assays were based on published procedures (30) . Reaction mixtures (60 ,l) contained 32P-end-labeled lux regulatory DNA (10,000-15,000 cpm), 50 mM NaCl, 1 mM MgCl2, acetylated bovine serum albumin (2 mg/ml), 2 (1994) radiolabeled DNA fragments were also used in MaxamGilbert A+G and C+T sequencing reactions (31) to generate a reference sequencing ladder. Radioactive bands were visualized by autoradiography.
Three different lux regulatory DNA fragments were endlabeled with T4 polynucleotide kinase and [yL32P]ATP (24) . For labeling the luxR sense strand, we used a HindIII-EcoRI lux DNA fragment from pAMS103 or an EcoRI-Pst I fragment from pAMS104. For labeling the luxI sense strand, an EcoRI-Pst I lux regulatory DNA fragment from pAMS103 was used.
RESULTS
Purification of LuxRAN from E. coli(pSC156). The tac promoter-controlled 5' luxR deletion on pSC156 directs the synthesis of a 95-aa polypeptide that serves as an autoinducer-independent activator of the V. fischeri luminescence genes in E. coli (13) . This pSC156-encoded polypeptide, LuxRAN, was found predominantly in the soluble supernatant fraction after ultracentrifugation of E. coli(pSC156) extracts (<10% in the pellet). LuxRAN was purified by ion-exchange and gel filtration column chromatography (Fig.  2) . About 1 mg of purified LuxRAN was obtained from a 5-liter culture of E. coli(pSC156). As determined by SDS/ PAGE LuxRAN had an apparent molecular weight of about 10,000, consistent with its predicted molecular weight of 10,695. Based on its elution from the gel filtration column, we believe that LuxRAN exists as a monomer in solution (data not shown). This finding is consistent with the conclusion based on molecular genetic analyses of LuxR that the region required for oligomerization resides in the N-terminal domain of the full-length polypeptide (14) . Only a small part of this oligomerization region exists on LuxRAN. We have not investigated whether LuxRAN forms oligomers at concentrations higher than that at which it was eluted from the gel filtration column.
DNA Mobility-Shift Studies: Purified LuxRAN Specificaily Binds to lux Regulatory DNA. LuxRAN bound to the 282-bp wild-type lux regulatory DNA-containing fragment, and apparently, two LuxRAN-DNA complexes formed. As the concentration of LuxRAN was increased, the extent of the DNA mobility shift increased and smearing of the bands was evident (Fig. 3A) . This type of result would be expected ifthe LuxRAN-DNA complexes were dissociating during electrophoresis or if a nucleoprotein complex were forming with DNA binding and additional LuxRAN binding to the DNAassociated LuxRAN as the concentration of the protein was increased (32, 33) . A shifted complex was not observed when pUC DNA was used in place oflux regulatory DNA (Fig. 3B ). This indicates a specificity of LuxRAN To begin to define the location of LuxRAN binding on the lux regulatory DNA, several different lux regulatory DNA deletion fragments were used in DNA mobility-shift experiments. The mobility-shift pattern observed with a 270-bp fragment of lux regulatory DNA with a deletion of the central 12-bp of the lux box was remarkably similar to the pattern observed when the 282-bp wild-type lux regulatory DNA fragment served as the target DNA (compare Fig. 3 C and A) . Because this 12-bp deletion abolishes autoinduction of luminescence in vivo (11) Rather, a pattern of hypersensitive bands and protected bands was observed in the region identified in the DNA mobility-shift experiments as the LuxRAN binding region (Fig. 4) . Also consistent with the DNA mobility-shift experiments, LuxRAN did not affect the DNase I banding pattern in the lux box region (Fig. 4) .
When RNAP by itself was added to the lux regulatory DNA, little or no DNase I protection was observed in the region of the luxI promoter (Fig. 4) . However, when both LuxRAN and RNAP were present, a clear footprint over the lux box and the luxI promoter region was observed, and the pattern of upstream hypersensitive and protected bands observed with LuxRAN alone was lost (Fig. 4) . The synergistic binding of RNAP and LuxRAN required the ao subunit of RNAP. When core RNAP was used in place of the holoenzyme the footprint was not present (data not shown). When the DNA contained a mutation in the lux box there was no DNase I protection of the lux box region and there was (34) . Addition of CRP alone to the lux regulatory DNA resulted in a footprint over the region previously shown to be protected by this protein (21) . When LuxRAN or LuxRAN and RNAP were included in the reaction mixtures with CRP, the DNase I protection pattern was similar to that obtained with CRP alone (Fig. 5) . At (Fig. 2) . We have termed the recombinant protein LuxRA&N.
As indicated by the results of DNase I footprint experiments, LuxRA&N and RNAP cooperate to protect the lux regulatory DNA in the region of the lux box (starting around luxI -54 through the luxI transcription start site to +6). Alone, RNAP only weakly protected a small area in the 10 region of luxI, and LuxRAN did not influence the sensitivity of the luxI promoter region to DNase I digestion (Fig. 4) . Protection of the luxI promoter region by LuxRAN (1994) t-absolute requirement for RNAP to achieve DNase I protection as described here for LuxRAN. Our evidence indicates that when eluted from the gel filtration column the purified LuxRAN existed as a monomer. Full-length LuxR is thought to function as a multimer, presumably a dimer (14) . It is possible that full-length multimeric LuxR would not exhibit an absolute dependence on RNAP for DNase I protection of the lux box. It is also possible that under the conditions used in the DNase I protection experiments, LuxRAN existed in an oligomeric state.
Both gel mobility studies and DNase I protection studies indicate that purified LuxRAN by itself interacts with lux regulatory DNA in a region upstream of the lux box (Figs. 3  and 4) . This upstream region encompasses the CRP-binding site (Fig. 1) . In the gel shift experiments the mobility of the complexes decreased with increasing concentration of LuxRAN. One interpretation of this result is that two discrete complexes formed. Perhaps one complex consisted of oligomers more tightly bound to the DNA, and the other consisted of monomers more loosely bound to the DNA. The smearing could have resulted from a dissociation of loosely bound complexes during gel electrophoresis. Another interpretation of this sort of pattern is that a nucleoprotein complex formed, with secondary binding of LuxRAN molecules to DNA-bound LuxRAN (32) . The DNase I protection experiments also showed a peculiar pattern in which a number ofhypersensitive bands were the most obvious result of the addition of purified LuxRAN. Like the DNA mobility-shift results, this is consistent with the formation of a nucleoprotein complex in which the DNA bends around a protein core (32, 33) .
By using DNase I protection assays we showed that under some conditions CRP not only interfered with LuxRAN binding in the absence of RNAP but also interfered with the synergistic binding of LuxRAN and RNAP to the lux box and the luxI promoter (Fig. 5) 
